Jump Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Jump Financial’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.97M	Buy	867,900 +391,422	+82%	+$1.3M	0.02%	726
2026 Q1	$1.71M	Buy	476,478 +358,278	+303%	+$1.42M	0.02%	722
2025 Q4	$415K	Sell	118,200 -103,838	-47%	-$356K	0.01%	1400
2025 Q3	$724K	Sell	222,038 -215,257	-49%	-$678K	0.01%	1151
2025 Q2	$1.07M	Buy	437,295 +183,572	+72%	+$930K	0.01%	953
2025 Q1	$1.69M	Buy	+253,723	New	+$2.51M	0.02%	634
2023 Q4	–	Sell	-39,463	Closed	-$809K	–	2163
2023 Q3	$809K	Buy	+39,463	New	+$717K	0.03%	778
2023 Q2	–	Sell	-44,278	Closed	-$758K	–	2098
2023 Q1	$758K	Buy	+44,278	New	+$867K	0.03%	714
2022 Q2	–	Sell	-16,100	Closed	-$255K	–	1955
2022 Q1	$255K	Sell	16,100 -10,500	-39%	-$181K	0.01%	1166
2021 Q4	$581K	Buy	+26,600	New	+$726K	0.04%	590

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jump Financial's RCKT Position: Q2 2026 in Review

Jump Financial increased its Rocket Pharmaceuticals (RCKT) stake by 82% in Q2 2026, buying an estimated $1.3M and bringing the position to 867,900 shares worth $2.97M. The position accounts for 0.02% of the portfolio, ranked #726.

Jump Financial first reported a position in RCKT in Q4 2021 and has held it in 10 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Jump Financial held 867,900 shares of Rocket Pharmaceuticals worth $2.97M as of Q2 2026.
Jump Financial bought 391,422 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.3M.
Rocket Pharmaceuticals made up 0.02% of Jump Financial's portfolio in Q2 2026, its #726 holding.
Jump Financial first reported a position in Rocket Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.